Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by 88guy88on Jan 11, 2020 3:39pm
73 Views
Post# 30542665

RE:Good opportunity

RE:Good opportunity Don't think so.....unless you mean its gonna soar down 80%....that is more likely....its way way overpriced

the RSI is 83.63....way way overbought as 70 is considered to be overbought...it showed signs of  the buyers drying up on Friday and that will continue next week as  the charts revert to the mean.....

the other problem is you can't put a value on the stock as the fundamentals don't exist....no sales no revenue no profit....just a speculation.....
<< Previous
Bullboard Posts
Next >>